JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M513014200 on January 5, 2006

J. Biol. Chem., Vol. 281, Issue 10, 6734-6741, March 10, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/10/6734    most recent
M513014200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ikeda, H.
Right arrow Articles by Sakai, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ikeda, H.
Right arrow Articles by Sakai, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

CCAAT Enhancer-binding Protein {alpha} Suppresses the Rat Placental Glutathione S-Transferase Gene in Normal Liver*

Hiromi Ikeda{ddagger}, Kazuki Omoteyama{ddagger}, Kazuhiko Yoshida§, Shinzo Nishi{ddagger}, and Masaharu Sakai{ddagger}1

From the Departments of {ddagger}Biochemistry and §Ophthalmology, Hokkaido University Graduate School of Medicine, N15, W7, Kita-Ku, Sapporo 060-8638, Japan and the Department of Health Sciences, Hokkaido University School of Medicine, N12, W5, Kita-Ku, Sapporo 060-0812, Japan

The rat placental glutathione S-transferase (GST-P), an isozyme of glutathione S-transferase, is not expressed in normal liver but is highly induced at an early stage of chemical hepatocarcinogenesis and in hepatomas. Recently, we reported that the NF-E2 p45-related factor 2 (Nrf2)/MafK heterodimer binds to GST-P enhancer 1 (GPE1), a strong enhancer of the GST-P gene, and activates this gene in preneoplastic lesions and hepatomas. In addition to the positive regulation during hepatocarcinogenesis, negative regulatory mechanisms might work to repress GST-P in normal liver, but this remains to be clarified. In this work, we identify the CCAAT enhancer-binding protein {alpha} (C/EBP{alpha}) as a negative regulator that binds to GPE1 and suppresses GST-P expression in normal liver. C/EBP{alpha} binds to part of the GPE1 sequence, and the binding of Nrf2/MafK and C/EBP{alpha} to GPE1 is mutually exclusive. In a transient-transfection analysis, C/EBP{alpha} activated GPE1 in F9 embryonal carcinoma cells but strongly inhibited GPE1 activity in hepatoma cells. The expression of C/EBP{alpha} was specifically suppressed in GST-P-positive preneoplastic foci in the livers of carcinogentreated rats. A chromatin immunoprecipitation analysis showed that C/EBP{alpha} bound to GPE1 in the normal liver in vivo but did not bind in preneoplastic hepatocytes. Introduction of the C/EBP{alpha} gene fused with the estrogen receptor ligand-binding domain into hepatoma cells, and subsequent activation by beta-estradiol led to the suppression of endogenous GST-P expression. These results indicate that C/EBP{alpha} is a negative regulator of GST-P gene expression in normal liver.


Received for publication, December 6, 2005 , and in revised form, January 5, 2006.

* This work was supported by grants-in-aid from the Saitama Medical School Research Center for Genomic Medicine, Ministry of Education, Science, Sports and Culture of Japan, and the YASUDA Medical Research Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Dept. of Health Sciences, Hokkaido University School of Medicine, N12, W5, Kita-Ku, Sapporo 060-0812, Japan. Tel.: 81-11-706-3407; Fax: 81-11-706-3407; E-mail: m_sakai{at}med.hokudai.ac.jp.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
J. Y. Lee, C. Y. Han, J. W. Yang, C. Smith, S. K. Kim, E. Y.-H. P. Lee, S. G. Kim, and K. W. Kang
Induction of Glutathione Transferase in Insulin-Like Growth Factor Type I Receptor-Overexpressed Hepatoma Cells
Mol. Pharmacol., October 1, 2007; 72(4): 1082 - 1093.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. J. McFie, G.-L. Wang, N. A. Timchenko, H. L. Wilson, X. Hu, and W. J. Roesler
Identification of a Co-repressor That Inhibits the Transcriptional and Growth-Arrest Activities of CCAAT/Enhancer-binding Protein {alpha}
J. Biol. Chem., June 30, 2006; 281(26): 18069 - 18080.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.